AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

LTR PHARMA LTD

0.375

+0.000

Volume:224.05K

Turnover:84.18K

Market Cap:67.87M

PE:-8.04

High:0.390

Open:0.385

Low:0.365

Close:0.375

Loading ...

Overview Company News Filings

LTR Pharma Completes Pre-Investigational New Drug Meeting with US FDA

MT Newswires Live

LTR Pharma dips -6% as US growth plans confuse with two identical products to be launched

The Market Herald

BRIEF-Ltr Pharma Says FDA Provides Path To Approval For Spontan

LTR Pharma Ltd - FDA Provides Path to Approval for Spontan

THOMSON REUTERS

Here's Why We're Not Too Worried About LTR Pharma's (ASX:LTP) Cash Burn Situation

Simply Wall St.

LTR Pharma Joins Forces with Pharmaceutical Wholesaler for Erectile Dysfunction Treatment Distribution; Shares Up 12%

MT Newswires Live

BRIEF-LTR Pharma Signs National Pharmacy Distribution Agreement With Symbion

BUZZ-Australia's LTR Pharma rises on distribution deal for its erectile dysfunction product

LTR Pharma - Signs National Pharmacy Distribution Agreement With Symbion

THOMSON REUTERS

BRIEF-LTR Pharma Announces Access Agreement With Men's Health Downunder

LTR Pharma pairs with Men’s Health Downunder for supply of erectile dysfunction spray

The Market Herald

ASX Market Open: Pre-Chrissy slowdown to turn into full-blown plunge after Powell preaches caution | Dec 19, 2024

The Market Herald

LTR Pharma - Access Agreement With Men's Health Downunder to Facilitate Supply of Spontan

THOMSON REUTERS

LTR Pharma's JV Partner Launches Online Health Platform Ahead of Target

MT Newswires Live

ASX Market Update: Index surprised as jobless rate falls to 3.9% | December 12, 2024

The Market Herald

LTR Pharma launches mix of online e-store, telehealth service to boost prescriptions

The Market Herald

LTR Pharma Ltd-Early Launch of Online Mens Health Platform

THOMSON REUTERS

BUZZ-Australia's LTR Pharma slides on discounted placement

BRIEF-Ltr Pharma Secures Binding Commitments To Raise A$25 Million

LTR Pharma Ltd - Secures Binding Commitments to Raise a$25 Mln

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LTP.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LTP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTP.AU\",,,,,undefined,":{"symbol":"LTP.AU","market":"AU","secType":"STK","nameCN":"LTR PHARMA LTD","latestPrice":0.375,"timestamp":1746079920000,"preClose":0.375,"halted":0,"volume":224045,"delay":0,"nameEN":"LTR PHARMA LTD","floatShares":97895250,"shares":180977728,"eps":-0.046646,"marketStatus":"Closed","change":0,"latestTime":"05-01 16:12:00 AEST","open":0.385,"high":0.39,"low":0.365,"amount":84183,"amplitude":0.066667,"askPrice":0.385,"askSize":20000,"bidPrice":0.375,"bidSize":2971,"shortable":3,"etf":0,"ttmEps":-0.046646,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746144000000},"marketStatusCode":5,"adr":0,"listingDate":1702126800000,"exchange":"ASX","adjPreClose":0.375,"openAndCloseTimeList":[[1746057600000,1746079200000]],"volumeRatio":0.325338,"lotSize":0,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTP.AU\",,,,,undefined,":{"symbol":"LTP.AU","floatShares":97895250,"roa":"-20.56%","roe":"-33.62%","lyrEps":-0.0499,"volumeRatio":0.325338,"shares":180977728,"dividePrice":0,"high":0.39,"amplitude":0.066667,"preClose":0.375,"low":0.365,"week52Low":0.245,"pbRate":"1.98","psRate":"135.81","week52High":2.15,"institutionHeld":0,"latestPrice":0.375,"committee":-0.741326,"eps":-0.046646,"divideRate":0,"volume":224045,"delay":0,"ttmEps":-0.046646,"open":0.385,"prevYearClose":0.81,"prevWeekClose":0.375,"prevMonthClose":0.375,"prevQuarterClose":0.46,"fiveDayClose":0.36,"twentyDayClose":0.46,"sixtyDayClose":0.72},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LTP.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522892089","title":"LTR Pharma Completes Pre-Investigational New Drug Meeting with US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2522892089","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522892089?lang=en_us&edition=fundamental","pubTime":"2025-03-26 14:26","pubTimestamp":1742970370,"startTime":"0","endTime":"0","summary":"LTR Pharma  said it completed a successful pre-investigational new drug meeting with the US Food and Drug Administration, providing a defined path to approval for its SPONTAN intranasal spray, according to a Wednesday Australian bourse filing.The meeting resulted in an alignment on a streamlined clinical development path, including one pivotal safety and efficacy trial and a multi-dose pharmacokinetic study.The FDA broadly endorsed LTR's non-clinical toxicology and chemistry, manufacturing and controls development plans. It plans to investigate the ability to use additional clinical trial data for the US with other regulatory submissions in key global markets.It also plans to introduce its vardenafil-based nasal spray Roxus into the US market. Roxus is being developed together with an Australian pharmaceutical partner in Australia and testing is being conducted to establish stability and shelf-life.Its shares fell 9% as of market close on Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","XKO.AU","XJO.AU","LTP.AU","BK7096"],"gpt_icon":0},{"id":"2522898712","title":"LTR Pharma dips -6% as US growth plans confuse with two identical products to be launched","url":"https://stock-news.laohu8.com/highlight/detail?id=2522898712","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522898712?lang=en_us&edition=fundamental","pubTime":"2025-03-26 10:54","pubTimestamp":1742957640,"startTime":"0","endTime":"0","summary":"LTR Pharma  has unveiled its latest grand plan to further expand into the U.S. market – with a product called Roxus it says taps into “personalised healthcare.”Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.But markets haven’t liked the news: Shares were down -6.3% heading in early afternoon trades on Wednesday. That could be because of confusion around what Roxus is, as opposed to LTR Pharma’s flagship drug SPONTAN, and whether or not Roxus will require years of clinical trials.“LTR Pharma is advancing a dual-track US market strategy with the introduction of our new product, Roxus, a vardenafil-based nasal spray targeting the growing personalised healthcare sector,” LTR wrote on Wednesday.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified fin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/ltr-pharma-dips-6-as-us-growth-plans-confuse-with-two-identical-products-to-be-launched-2025-03-26/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7096","LTP.AU"],"gpt_icon":0},{"id":"2522854505","title":"BRIEF-Ltr Pharma Says FDA Provides Path To Approval For Spontan","url":"https://stock-news.laohu8.com/highlight/detail?id=2522854505","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522854505?lang=en_us&edition=fundamental","pubTime":"2025-03-26 09:31","pubTimestamp":1742952699,"startTime":"0","endTime":"0","summary":"BRIEF-Ltr Pharma Says FDA Provides Path To Approval For SpontanMarch 26 (Reuters) - LTR Pharma Ltd LTP.AX:FDA PROVIDES PATH TO APPROVAL FOR SPONTANFurther company coverage: LTP.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q81IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTP.AU","BK7096"],"gpt_icon":0},{"id":"2522839353","title":"LTR Pharma Ltd - FDA Provides Path to Approval for Spontan","url":"https://stock-news.laohu8.com/highlight/detail?id=2522839353","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522839353?lang=en_us&edition=fundamental","pubTime":"2025-03-26 05:59","pubTimestamp":1742939987,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q81IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","LTP.AU"],"gpt_icon":0},{"id":"2516583297","title":"Here's Why We're Not Too Worried About LTR Pharma's (ASX:LTP) Cash Burn Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2516583297","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516583297?lang=en_us&edition=fundamental","pubTime":"2025-03-01 07:19","pubTimestamp":1740784772,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. Indeed, LTR Pharma  stock is up 107% in the last year, providing strong gains for shareholders. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse.So notwithstanding the buoyant share price, we think it's well worth asking whether LTR Pharma's cash burn is too risky. For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.When Might LTR Pharma Run Out Of Money?How Is LTR Pharma's Cash Burn Changing Over Time?Since it has a market capitalisation of AU$109m, LTR Pharma's AU$5.3m in cash burn equates to about 4.9% of its market value. That's a low proportion, so","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-were-not-too-231932087.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LTP.AU","BK7096"],"gpt_icon":0},{"id":"2505080852","title":"LTR Pharma Joins Forces with Pharmaceutical Wholesaler for Erectile Dysfunction Treatment Distribution; Shares Up 12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505080852","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505080852?lang=en_us&edition=fundamental","pubTime":"2025-01-23 09:55","pubTimestamp":1737597326,"startTime":"0","endTime":"0","summary":"LTR Pharma  partnered with pharmaceutical wholesaler Symbion to establish national distribution capabilities for Spontan, a nasal spray treatment for erectile dysfunction, according to a Wednesday filing with the Australian bourse.Symbion will offer warehousing, inventory management, and nationwide distribution services for Spontan starting in March, the filing said.The operational integration is scheduled for rollout in the second quarter, per the filing.Shares were up 12% in midday trade Thursday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","LTP.AU"],"gpt_icon":0},{"id":"2505753623","title":"BRIEF-LTR Pharma Signs National Pharmacy Distribution Agreement With Symbion","url":"https://stock-news.laohu8.com/highlight/detail?id=2505753623","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505753623?lang=en_us&edition=fundamental","pubTime":"2025-01-22 09:31","pubTimestamp":1737509460,"startTime":"0","endTime":"0","summary":"BRIEF-LTR Pharma Signs National Pharmacy Distribution Agreement With SymbionJan 22  - LTR Pharma Ltd LTP.AX:SIGNS NATIONAL PHARMACY DISTRIBUTION AGREEMENT WITH SYMBIONAGREEMENT ENABLES NATIONWIDE DISTRIBUTION OF SPONTAN VIA SYMBION'S EXTENSIVE NETWORKFurther company coverage: LTP.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250122:nFWN3OH20B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTP.AU","BK7096"],"gpt_icon":0},{"id":"2505758441","title":"BUZZ-Australia's LTR Pharma rises on distribution deal for its erectile dysfunction product","url":"https://stock-news.laohu8.com/highlight/detail?id=2505758441","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505758441?lang=en_us&edition=fundamental","pubTime":"2025-01-22 09:22","pubTimestamp":1737508953,"startTime":"0","endTime":"0","summary":"** Shares of LTR Pharma    rise 7.9% to A$0.755   ** The biopharmaceutical firm rose as much as 17.9% earlier in the day, their biggest intraday gain since early November   ** Co enters an agreement with Australian pharmaceutical wholesaler Symbion for nation-wide distribution for SPONTAN   ** SPONTAN is LTR Pharma's lead product for treatment of erectile dysfunction   ** About 1.2 mln shares change hands, compared with 30-day average trading volume of 669,941 shares    ** Stock down 13.6% YTD, as of last close  ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XKO.AU","XAO.AU","BK7096","LTP.AU","XJO.AU"],"gpt_icon":0},{"id":"2505871587","title":"LTR Pharma - Signs National Pharmacy Distribution Agreement With Symbion","url":"https://stock-news.laohu8.com/highlight/detail?id=2505871587","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505871587?lang=en_us&edition=fundamental","pubTime":"2025-01-22 05:40","pubTimestamp":1737495631,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nFWN3OH20B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","LTP.AU"],"gpt_icon":0},{"id":"2492684167","title":"BRIEF-LTR Pharma Announces Access Agreement With Men's Health Downunder","url":"https://stock-news.laohu8.com/highlight/detail?id=2492684167","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492684167?lang=en_us&edition=fundamental","pubTime":"2024-12-19 09:06","pubTimestamp":1734570361,"startTime":"0","endTime":"0","summary":"BRIEF-LTR Pharma Announces Access Agreement With Men's Health DownunderDec 19 (Reuters) - LTR Pharma Ltd LTP.AX:ACCESS AGREEMENT WITH MEN'S HEALTH DOWNUNDER TO FACILITATE SUPPLY OF SPONTANFurther company coverage: LTP.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nFWN3NJ109:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","LTP.AU"],"gpt_icon":0},{"id":"2492657811","title":"LTR Pharma pairs with Men’s Health Downunder for supply of erectile dysfunction spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2492657811","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492657811?lang=en_us&edition=fundamental","pubTime":"2024-12-19 06:37","pubTimestamp":1734561420,"startTime":"0","endTime":"0","summary":"LTR Pharma Ltd  has entered an access agreement with specialised health provider Men’s Health Downunder  centred on the supply of its lead nasal spray product for erectile dysfunction.The company aims to introduce the product, SPONTAN, to the market, while also gathering real-world patient data. For this, a partnership with MHDU – which is responsible for an Australia-wide network of pharmacists, GPs, nurses, and allied health professionals working around urological healthcare – will be a boon.LTR Pharma will also have access to MHDU’s extensive referral network, which includes general practitioners, urologists, and sexual health clinics – with more than 1,000 patients seen annually through the latter.MHDU founder and executive chairman Brad Butt said this agreement was an important step for both parties.“This collaboration with LTR Pharma enhances our ability to provide innovative solutions for men’s health concerns,” he said.The material provided in this article is for information on","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/ltr-pharma-pairs-with-mens-health-downunder-for-supply-of-erectile-dysfunction-spray-2024-12-19/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7096","LTP.AU"],"gpt_icon":0},{"id":"2492500751","title":"ASX Market Open: Pre-Chrissy slowdown to turn into full-blown plunge after Powell preaches caution | Dec 19, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2492500751","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492500751?lang=en_us&edition=fundamental","pubTime":"2024-12-19 05:38","pubTimestamp":1734557880,"startTime":"0","endTime":"0","summary":"Hesitation from Jerome Powell and the Federal Reserve regarding U.S. rates – and Wall Street’s panicked selling that followed – is creeping into Australian markets, with ASX 200 futures tipped to open as much as -1.8% lower today.The Fed delivered a “notably hawkish cut” before immediately warning investors there would be a major slowdown when it comes to trims through next year.It wasn’t just slowing rate cuts the Fed Reserve boss spoke about either; he even refused to rule out more hikes. “You don’t rule things completely in or out in this world,” the central bank’s chairman mused after the meeting.Dual-listed Patriot Battery Minerals  may dodge the impending ASX slump after selling a 9.9% stake to German automaker Volkswagen for $48 million. The deal is the first time Volkswagen has chased lithium supply.GenusPlus Group  has caught HotCopper investors’ attention through the morning after bagging a contract for the Hunter-Central Coast Renewable Energy Zone.Iron Ore has dropped 2%, t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-open-pre-chrissy-slowdown-to-turn-into-full-blown-plunge-after-powell-preaches-caution-dec-19-2024-2024-12-19/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["IPL.AU","LTP.AU","BK7055","BK7095","BK4585","ELD.AU","BK7096","BK4588","PMT.AU","BK7511","GNP.AU","BK7505","BK4096","BK7025","BK7135","ANZ.AU","BK7117"],"gpt_icon":0},{"id":"2492154000","title":"LTR Pharma - Access Agreement With Men's Health Downunder to Facilitate Supply of Spontan","url":"https://stock-news.laohu8.com/highlight/detail?id=2492154000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492154000?lang=en_us&edition=fundamental","pubTime":"2024-12-19 05:20","pubTimestamp":1734556855,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ109:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LTP.AU","BK7096"],"gpt_icon":0},{"id":"2491366661","title":"LTR Pharma's JV Partner Launches Online Health Platform Ahead of Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2491366661","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491366661?lang=en_us&edition=fundamental","pubTime":"2024-12-13 07:20","pubTimestamp":1734045600,"startTime":"0","endTime":"0","summary":"LTR Pharma  said its joint venture partner, Restorative Sexual Health Clinic, launched an online healthcare platform ahead of schedule for Australian men, according to a Thursday filing with the Australian bourse.The platform will provide evidence-based care for erectile dysfunction through telehealth consultations, the filing said.The clinical-stage pharmaceutical company also noted that the platform provides an additional channel for delivering Spontan, its intranasal spray treatment for erectile dysfunction.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","BK7096","XKO.AU","LTP.AU","XJO.AU"],"gpt_icon":0},{"id":"2490828059","title":"ASX Market Update: Index surprised as jobless rate falls to 3.9% | December 12, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2490828059","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490828059?lang=en_us&edition=fundamental","pubTime":"2024-12-12 11:44","pubTimestamp":1733975040,"startTime":"0","endTime":"0","summary":"The ASX200 has been down 0.2% at 8337 points in afternoon trade.The Aussie unemployment rate fell to 3.9% in November, signaling an ongoing tight labour market, despite a slowing economy. More than 35,000 jobs were added to the economy in November, pushing the jobless rate below 4% for the first time since March.Industrials has been the worst performing sector, down 1.1%, followed by Real Estate, down 0.9% and Telecommunication, down 0.6%. Energy has been the best performer, up 0.6%, followed by Information Technology, up half a percent .Syrah Resources has been down 28% after declaring a force majeure at its Mozambique-based graphite play.LTR Pharma has been up 3.75% after launching an online men’s health platform to “facilitate the regulated prescription” of its nasal spray Viagra product.GTI Energy has been up 33% after increasing the mineral resource estimate  of its Lo Herma uranium project in Wyoming by 50% for a total of 8.57 million pounds . The project – located in Wyoming’s P","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-update-index-surprised-as-jobless-rate-falls-to-3-9-december-12-2024-2024-12-12/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["MRE.AU","GTR.AU","BK7095","LTP.AU","SYR.AU","BK7507","BK7096"],"gpt_icon":0},{"id":"2490817560","title":"LTR Pharma launches mix of online e-store, telehealth service to boost prescriptions","url":"https://stock-news.laohu8.com/highlight/detail?id=2490817560","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490817560?lang=en_us&edition=fundamental","pubTime":"2024-12-12 07:54","pubTimestamp":1733961240,"startTime":"0","endTime":"0","summary":"LTR Pharma  has launched an online men’s health platform to “facilitate the regulated prescription” of its nasal spray Viagra product.Called SPONTAN, the company’s flagship product – which originally landed it on the radars of investment bank analysts when it floated on the market, not just retail – is a fast-acting Viagra alternative that is applied as a nasal spray.But that interest from investment bank analysts  comes with responsibilities – in other words: Live up to the hype.And that may be a problem for LTP right now. After touching $2/sh in October, the company’s share price has since sunk to 93cps – it listed last December just above 30cps.Enter the e-store – or telehealth service, depending on how you look at it. To be fair, it’s both. Existing partner Restorative Health Clinic  is helping to launch the service.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/ltr-pharma-launches-mix-of-online-e-store-telehealth-service-to-boost-prescriptions-2024-12-12/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["LTP.AU","BK7113","RHC.AU","BK7096"],"gpt_icon":0},{"id":"2490813551","title":"LTR Pharma Ltd-Early Launch of Online Mens Health Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2490813551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490813551?lang=en_us&edition=fundamental","pubTime":"2024-12-12 05:28","pubTimestamp":1733952517,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nTUE4PLQRW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","LTP.AU"],"gpt_icon":0},{"id":"2490372200","title":"BUZZ-Australia's LTR Pharma slides on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2490372200","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490372200?lang=en_us&edition=fundamental","pubTime":"2024-12-10 10:46","pubTimestamp":1733798799,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's LTR Pharma slides on discounted placement** Shares of LTR Pharma LTP.AX fall as much as 8.6% to A$0.96, their lowest level since Aug. 12** Aussie biotech firm gets binding commitments for A$25 mln private placementat A$0.92/shr, a 12.4% discount to last close** Says funds to speed development, commercialisation of its SPONTAN nasal spray treatment for erectile dysfunction** Trading vol of 915,000+ shares tops 30-day avg of ~632,000** Stock has now surged ~190% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nL4N3NB05M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTP.AU","BK7096"],"gpt_icon":0},{"id":"2490039055","title":"BRIEF-Ltr Pharma Secures Binding Commitments To Raise A$25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2490039055","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490039055?lang=en_us&edition=fundamental","pubTime":"2024-12-10 09:41","pubTimestamp":1733794865,"startTime":"0","endTime":"0","summary":"BRIEF-Ltr Pharma Secures Binding Commitments To Raise A$25 MillionDec 10 (Reuters) - LTR Pharma Ltd LTP.AX:SECURES BINDING COMMITMENTS TO RAISE A$25 MILLIONISSUE PRICE OF A$0.92 PER SHAREFurther company coverage: LTP.AX ((Reuters.Briefs@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nFWN3NA1G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTP.AU","BK7096"],"gpt_icon":0},{"id":"2490350089","title":"LTR Pharma Ltd -  Secures Binding Commitments to Raise a$25 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2490350089","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490350089?lang=en_us&edition=fundamental","pubTime":"2024-12-10 06:07","pubTimestamp":1733782051,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LTP.AU","BK7096"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LTP.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LTP.AU\",market:\"AU\",,,undefined,":[]}}